loader
Please Wait
Applying Filters...
menu
    • menu

    Looking for Granule / Pellet? Find Controlled & Modified Release & other pharma excipients for Granule / Pellet dosage forms on PharmaCompass.

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    View Presentation

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-Default-Wallpaper

    Virtual Booth

    Contact Supplier

    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Acetyl Triethyl Citrate

    02 1Acetyl tri-n-butyl citrate

    03 3Ethyl Acrylate Methyl Methacrylate Copolymer

    04 1Ethyl Cellulose

    05 3Methacrylic Acid & Ethyl Acrylate Copolymer

    06 1Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer

    07 1Sodium Lauryl Sulfate

    08 1Talc Excipient

    09 1Tri-n-butyl Citrate

    10 1Triethyl Citrate

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass

    01

    Evonik

    Germany
    arrow
    ESF Europe
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

    Dosage Form : Granule / Pellet

    Grade : Oral

    Brand Name : EUDRAGIT® RL 30 D

    Application : Controlled & Modified Release

    Excipient Details : Eudragit RL 30 D(aqueous dispersion) is a sustained release polymer for customized release profiles, used in combination with EUDRAGIT® RS.

    Pharmacopoeia Ref : NA

    Technical Specs : NA

    Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer

    Dosage Form : Granule / Pellet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

    Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer

    Dosage Form : Granule / Pellet

    Category : Controlled & Modified Release

    Brand : EUDRAGIT® RL 30 D

    Applications : Eudragit RL 30 D(aqueous dispersion) is a sustained release polymer for customized release profiles, used in combination with EUDRAGIT® RS.

    Pharmacopoeia Ref : NA

    Technical Specs : NA

    Grade : Oral

    arrow
    EUDRAGIT® RL 30 D

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    02

    Evonik

    Germany
    arrow
    ESF Europe
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

    Dosage Form : Granule / Pellet

    Grade : Oral

    Brand Name : EUDRAGIT® NE 30 D

    Application : Controlled & Modified Release

    Excipient Details : Eudragit NE 30 D (aqueous dispersion) is a highly flexible sustained release polymer used for coating (without plasticizer) in OSDs.

    Pharmacopoeia Ref : NA

    Technical Specs : NA

    Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer

    Dosage Form : Granule / Pellet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

    Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer

    Dosage Form : Granule / Pellet

    Category : Controlled & Modified Release

    Brand : EUDRAGIT® NE 30 D

    Applications : Eudragit NE 30 D (aqueous dispersion) is a highly flexible sustained release polymer used for coating (without plasticizer) in OSDs.

    Pharmacopoeia Ref : NA

    Technical Specs : NA

    Grade : Oral

    arrow
    EUDRAGIT® NE 30 D

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    03

    Evonik

    Germany
    arrow
    ESF Europe
    Attending
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

    Dosage Form : Granule / Pellet

    Grade : Oral

    Brand Name : EUDRAGIT® NE 40 D

    Application : Controlled & Modified Release

    Excipient Details : EUDRAGIT® NE 40 D (aqueous dispersion) is a sustained release polymer used for coating tablets, granules and pellets.

    Pharmacopoeia Ref : NA

    Technical Specs : NA

    Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer

    Dosage Form : Granule / Pellet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothEvonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

    Ingredient(s) : Ethyl Acrylate Methyl Methacrylate Copolymer

    Dosage Form : Granule / Pellet

    Category : Controlled & Modified Release

    Brand : EUDRAGIT® NE 40 D

    Applications : EUDRAGIT® NE 40 D (aqueous dispersion) is a sustained release polymer used for coating tablets, granules and pellets.

    Pharmacopoeia Ref : NA

    Technical Specs : NA

    Grade : Oral

    arrow
    EUDRAGIT® NE 40 D

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    04

    Aeon Procare

    TALC

    arrow
    RNA Therapeutics
    Not Confirmed

    05

    Vertellus

    ACETYL TRIETHYL CITRATE (ATEC)

    arrow
    RNA Therapeutics
    Not Confirmed

    06

    Vertellus

    TRI-N-BUTYL CITRATE (TBC)

    arrow
    RNA Therapeutics
    Not Confirmed

    07

    Vertellus

    ACETYL TRI-N-BUTYL CITRATE (ATBC)

    arrow
    RNA Therapeutics
    Not Confirmed

    08

    Vertellus

    TRIETHYL CITRATE (TEC)

    arrow
    RNA Therapeutics
    Not Confirmed

    Vertellus

    U.S.A
    arrow
    RNA Therapeutics
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Granule / Pellet

    Grade : Oral

    Brand Name : Triethyl Citrate (TEC)

    Application : Controlled & Modified Release

    Excipient Details : Controlled-release coatings, Enteric coatings, Plasticizer in acrylic and cellulosic film coatings, Coalescing agent/film former for aqueous latex dispersions, Plasticizer in low-temperature hot-melt extrusion.

    Pharmacopoeia Ref : NF, FCC, JPE

    Technical Specs : Water soluble

    Ingredient(s) : Triethyl Citrate

    Dosage Form : Granule / Pellet

    Grade : Oral

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Triethyl Citrate

    Dosage Form : Granule / Pellet

    Category : Controlled & Modified Release

    Brand : TRIETHYL CITRATE (TEC)

    Applications : Controlled-release coatings, Enteric coatings, Plasticizer in acrylic and cellulosic film coatings, Coalescing agent/film former for aqueous latex dispersions, Plasticizer in low-temperature hot-melt extrusion.

    Pharmacopoeia Ref : NF, FCC, JPE

    Technical Specs : Water soluble

    Grade : Oral

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    09

    Corel Pharma Chem

    NUTRACOAT EC25D

    arrow
    RNA Therapeutics
    Not Confirmed

    10

    BASF

    KOLLICOAT MAE 100-55

    arrow
    RNA Therapeutics
    Not Confirmed

    11

    BASF

    KOLLICOAT MAE 100 P

    arrow
    RNA Therapeutics
    Not Confirmed

    12

    BASF

    KOLLICOAT MAE 30 DP

    arrow
    RNA Therapeutics
    Not Confirmed

    13

    BASF

    KOLLICOAT SR 30 D

    arrow
    RNA Therapeutics
    Not Confirmed

    BASF

    Germany
    arrow
    RNA Therapeutics
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Dosage Form : Granule / Pellet

    Grade :

    Brand Name : Kollicoat SR 30 D

    Application : Controlled & Modified Release

    Excipient Details : pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

    Pharmacopoeia Ref : Ph. Eur.: Poly(vinyl acetate) ...

    Technical Specs :

    Ingredient(s) : Polyvinyl Acetate, Sodium Lauryl Sulfate

    Dosage Form : Granule / Pellet

    Grade :

    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Ingredient(s) : Polyvinyl Acetate, Sodium Lauryl Sulfate

    Dosage Form : Granule / Pellet

    Category : Controlled & Modified Release

    Brand : KOLLICOAT SR 30 D

    Applications : pH-independent sustained release coating for small particles, pellets, granules and tablets. Sprayable polymeric film former. Flexible. Wash resistant.

    Pharmacopoeia Ref : Ph. Eur.: Poly(vinyl acetate) dispersion 30 per cent; USP: Polyvinyl Acetate Dispersion

    Technical Specs : Not Available

    Grade : Not Available

    arrow
    blank

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    14

    BASF

    KOLLICOAT PROTECT

    arrow
    RNA Therapeutics
    Not Confirmed